Abdominal vagal mediation of the satiety effects of CCK in rats

Roger D. Reidelberger, Jessica Hernandez, Bernd Fritzsch, Martin Hulce

Research output: Contribution to journalArticlepeer-review

97 Scopus citations


CCK type 1 (CCK1) receptor antagonists differing in blood-brain barrier permeability were used to test the hypothesis that satiety is mediated in part by CCK action at CCK1 receptors on vagal sensory nerves innervating the small intestine. Devazepide penetrates the blood-brain barrier; A-70104, the dicyclohexylammonium salt of Nα-3-quinolinoyl-D-Glu-N,N-dipentylamide, does not. At dark onset, non-food-deprived control rats and rats with subdiaphragmatic vagotomies received a bolus injection of devazepide (2.5 μmol/kg iv) or a 3-h infusion of A-70104 (3 μmol·kg -1·h-1 iv) either alone or coadministered with a 2-h intragastric infusion of peptone (0.75 or 1 g/h). Food intake was determined from continuous computer recordings of changes in food bowl weight. In control rats both antagonists stimulated food intake and attenuated the anorexic response to intragastric infusion of peptone. In contrast, only devazepide was effective in stimulating food intake in vagotomized rats. Thus endogenous CCK appears to act both at CCK1 receptors beyond the blood-brain barrier and by a CCK1 receptor-mediated mechanism involving abdominal vagal nerves to inhibit food intake.

Original languageEnglish (US)
Pages (from-to)R1005-R1012
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Issue number6 55-6
StatePublished - Jun 2004

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)


Dive into the research topics of 'Abdominal vagal mediation of the satiety effects of CCK in rats'. Together they form a unique fingerprint.

Cite this